The role of neoadjuvant chemotherapy in management of locally advanced cancer cervix: A systemic review

Oncology Reviews

Volumn 8, Issue 2, 2014, Pages

  Osman, Mohammed ^a  

^a General Organization for Teaching Hospitals and Institutes   (Egypt)

Author keywords

Neoadjuvant cervix chemotherapy; Systemic quality survival

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; NEDAPLATIN; PACLITAXEL; PLATINUM DERIVATIVE;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; BLADDER DYSFUNCTION; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; DYSPAREUNIA; FISTULA; HUMAN; INTESTINE OBSTRUCTION; LEG EDEMA; LEUKOPENIA; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PERIPHERAL NEUROPATHY; PROGRESSION FREE SURVIVAL; RADICAL HYSTERECTOMY; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CANCER; VAGINA DISEASE; VAGINAL DEHISCENCE;

EID: 84907270504     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.4081/oncol.2014.250     Document Type: Review

References (44)

1. Ferlay J, Shin HR, Bray F, et al: Cancer Incidence and Mortality Worldwide: IARC CancerBase No.10. Lyon, France: International Agency for Research on Cancer, 2010.
2. Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105 (2): 103-4, 2009.
3. Monk BJ, Tewari KS, Koh WJ: Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol 25 (20): 2952-65, 2007.
4. Thomas GM: Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Engl J Med 340 (15): 1198-200, 1999.
5. Green JA, Kirwan JM, Tierney JF, et al: Survival and recurrence after concomitant cehmotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001; 358: 781-6, 2001.
6. Tan LT, Zahra M: Long-term Survival and Late Toxicity after Chemoradiotherapy for Cervical Cancer d The Addenbrooke's Experience. Clinical Oncology 20: 358-364, 2008.
7. Huang HJ, Chang TC, Hong JH, et al: Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (
8. Panici, P.B., Scambia, G., Baiocchi, G., et al: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer, Vol 67, No. 2, pp. 372-379, 1998.
9. Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25: 603-605, 2010.
10. Shoji T, Takatori E, Saito T, et al: Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix. Cancer Chemother Pharmacol (2013) 71: 657-662. Published online: 23 December 2012.
11. Shen Y, Yang L, and Wang Z: Treatment of early bulky cervical cancer with neoadjuvant paclitaxel, carboplatin and cisplatin prior to laparoscopical radical hysterectomy and pelvic lymphadenectomy. ONCOLOGY LETTERS 3: 641-645, 2012.
12. Yamaguchi S, Nishimura R, Yaegashi N, et al: Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065). Oncol Rep. Aug;28(2): 487-493, 2012.
13. Pinheiro W, Pereira AK, Soares JM Jr, el al: Is the combination of mitomycin C, bleomycin and methotrexate effective as aneoadjuvant treatment for cervical cancer in women. Eur J Gynaecol Oncol. 32(1): 37-9, 2011.
14. Vizza E, Pellegrino A, Milani R, et al: Total laparoscopic radical hysterectomy and pelvic lymphadenectomy in locally advanced stage IB2-IIB cervical cancer patients after neoadjuvant chemotherapy. Eur J Surg Oncol. Apr;37(4): 364-9, 2011.
15. Mossa B, Mossa S, Corosu L, et al: Follow-up in a long-term randomized trial with neoadjuvant chemotherapy for squamous cell cervical carcinoma. Eur J Gynaecol Oncol. 31(5): 497-503, 2010.
16. Shoji T, Takatori E, Hatayama S, et al: Phase II study of tri-weekly cisplatin and irinotecan as neoadjuvant chemotherapyfor locally advanced cervical cancer. Oncol Lett.;1(3): 515-519, 2010.
17. Kumar JV, Doval DC, Rao R, et al: A retrospective study of patients with locally advanced cancer of the cervixtreated with neoadjuvant chemotherapy followed by radical surgery. Int J Gynecol Cancer. Apr;19(3): 417-22, 2009.
18. Cho Y, Kim D, Kim J, et al: Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer. J Gynecol Oncol Vol. 20, No. 1: 22-27, March 2009.
19. Kokawa K, Nishimura R, Fujii T, et al: Neoadjuvant chemotherapy with irinotecan and mitomycin-C for locally advanced squamous cell carcinoma of the uterine cervix. Anticancer Res. Jul-Aug;27(4C): 2721-7, 2007.
20. Sláma J, Cibula D, Freitag P, et al: Contribution of neoadjuvant chemotherapy for operability of cancers of the uterine cervix. Ceska Gynekol. Apr;72(2): 116-9, 2007.
21. Eddy G, Bundy B, Creasman W, et al: Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol. Aug; 106(2): 362-9. Epub 2007 May 9, 2007.
22. Choi YS, Sin J, Kim J, et al: Survival Benefits of Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy in Locally Advanced Chemoresistant Cervical Cancer. J Korean Med Sci; 21: 683-9, 2006.
23. Cai HB, Chen HZ, Yin HH: Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer. J Obstet Gynaecol Res. Jun;32(3): 315-23, 2006.
24. Termrungruanglert W, Tresukosol D, Vasuratna A, et al: Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2. Gynecol Oncol. May; 97(2): 576-81,2005.
25. Taneja A, Rajaram S, Agarwal S, et al: "Quick Cycle" neoadjuvant chemotherapy in squamous cell carcinoma of cervix. Indian J Pharmacol. 37: 320-4, 2005.
26. DeSouza NM, Soutter WP, Rustin G, et al: Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumour shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome. British Journal of Cancer. 90, 2326-2331, 2004.
27. Hwang YY, Moon H, Cho SH, Kim KT, et al: Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol. Jul;82(1): 88-93, 2001.
28. Napolitano U, Imperato F, Mossa B, et al: The role of neoadjuvant chemotherapy for squamous cell cervical cancer (Ib-IIIb): a long-term randomized trial. Eur J Gynaecol Oncol. 24(1): 51-9, 2003.
29. D'Agostino G, Distefano M, Greggi S, et al: Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin. Cancer Chemother Pharmacol. 2002 Mar;49(3): 256-60, 2002.
30. Benedetti-Panici P, Greggi S, Colombo A, et al: Neoadjuvant Chemotherapy and Radical Surgery Versus Exclusive Radiotherapy in Locally Advanced Squamous Cell Cervical Cancer: Results From the Italian Multicenter Randomized Study. Journal of Clinical Oncology, Vol 20, No 1 (January 1): pp 179-188, 2002.
31. Dueñas-Gonzalez A, López-Graniel C, González-Enciso A, et al: A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Annals of Oncology 14: 1278-1284, 2003.
32. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, et al: Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies. Annals of Oncology, Volume 13, Issue 8, pp 1212-1219, 2002.
33. Costa S, Terzano P, Santini D, et al: Neoadjuvant Chemotherapy in Cervical Carcinoma. Regulators of Cell Cycle, Apoptosis, and Proliferation as Determinants of Response to Therapy and Disease Outcome. Am J Clin Pathol;116: 729-737, 2001.
34. MacLeod C, O'Donnell A, Tattersall MH, et al: Locally advanced cervix cancer: chemotherapy prior to definitive surgery or radiotherapy. A single institutional experience. Australas Radiol. Nov;45(4): 491-5, 2001.
35. Aoki Y, Tomita M, Sato T, et al: Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol. Nov;83(2): 263-7, 2001.
36. Hwang Y, Moon H, Cho S, et al: Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol. Jul;82(1): 88-93, 2001.
37. Chang TC, Lai CH, Hong JH, et al: Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol. Apr;18(8): 1740-7, 2000.
38. Zanetta G, Lissoni A, Pellegrino A, et al: Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol. Sep;9(9): 977-80, 1998.
39. Sardi J, Giaroli A, Sananes C, et al: Long-term follow-up of the first randomized trial using neoadjuvant chemotherapyin stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol. Oct;67(1): 61-9, 1997.
40. Lacava JA, Leone BA, Machiavelli M, et al: Vinorelbine as Neoadjuvant Chemotherapy in Advanced Cervical Carcinoma. Journal of Clinical Oncology, Vol 15, No 2 (February): pp 604-609, 1997.
41. Moher D, Liberati A, Tetzlaff J, el al: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ; 339 doi: http://dx.doi.org/10.1136/bmj.b2535, 2009.
42. Garg A, Hackam D, Tonelli M: Systematic Review and Meta-analysis: When One Study Is Just not Enough. Clin J Am Soc Nephrol 3: 253-260, 2008.
43. Morris M, Eifel PJ, Lu J, et al: Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: A randomized Radiation Therapy Oncology Group clinical trial. N Engl J Med 340: 1137-1143, 1999.
44. Lorusso D, Petrelli F, Coinu A, et al: A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecologic Oncology: Volume 133, Issue 1, 117-123, 2014.